This implied that SCARA5 suppression in HCC cells, potentially induced by allelic loss, DNA hypermethylation in the promoter CpG island, histone modifications, could promote cell proliferation and other malignant phenotypes in HCC. The gene discussed is SCARA5; the disease is hepatocellular carcinoma.